HK1226396B - 用於大規模生產1-[(2-溴苯基)磺醯基]-5-甲氧基-3-[(4-甲基-1-呱嗪基)甲基]-1h-吲哚二甲磺酸鹽一水合物的方法 - Google Patents
用於大規模生產1-[(2-溴苯基)磺醯基]-5-甲氧基-3-[(4-甲基-1-呱嗪基)甲基]-1h-吲哚二甲磺酸鹽一水合物的方法Info
- Publication number
- HK1226396B HK1226396B HK16114655A HK16114655A HK1226396B HK 1226396 B HK1226396 B HK 1226396B HK 16114655 A HK16114655 A HK 16114655A HK 16114655 A HK16114655 A HK 16114655A HK 1226396 B HK1226396 B HK 1226396B
- Authority
- HK
- Hong Kong
- Prior art keywords
- methyl
- bromophenyl
- piperazinyl
- sulfonyl
- methoxy
- Prior art date
Links
- XKDCUJBWVGDNSH-UHFFFAOYSA-N 1-(2-bromophenyl)sulfonyl-5-methoxy-3-[(4-methylpiperazin-1-yl)methyl]indole;methanesulfonic acid;hydrate Chemical compound O.CS(O)(=O)=O.CS(O)(=O)=O.C12=CC(OC)=CC=C2N(S(=O)(=O)C=2C(=CC=CC=2)Br)C=C1CN1CCN(C)CC1 XKDCUJBWVGDNSH-UHFFFAOYSA-N 0.000 title 1
- 238000011031 large-scale manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN5537CH2013 IN2013CH05537A (zh) | 2013-12-02 | 2014-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1226396B true HK1226396B (zh) | 2017-09-29 |
Family
ID=54199404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16114655A HK1226396B (zh) | 2013-12-02 | 2016-12-23 | 用於大規模生產1-[(2-溴苯基)磺醯基]-5-甲氧基-3-[(4-甲基-1-呱嗪基)甲基]-1h-吲哚二甲磺酸鹽一水合物的方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9540321B2 (zh) |
| EP (1) | EP3077375B1 (zh) |
| JP (1) | JP6151453B2 (zh) |
| KR (1) | KR101808792B1 (zh) |
| CN (1) | CN105814020B (zh) |
| AP (1) | AP2016009224A0 (zh) |
| AU (1) | AU2014358682B2 (zh) |
| BR (1) | BR112016010788B1 (zh) |
| CA (1) | CA2929309C (zh) |
| CY (1) | CY1119298T1 (zh) |
| DK (1) | DK3077375T3 (zh) |
| EA (1) | EA028038B1 (zh) |
| ES (1) | ES2638856T3 (zh) |
| HK (1) | HK1226396B (zh) |
| HR (1) | HRP20171245T1 (zh) |
| HU (1) | HUE036008T2 (zh) |
| IL (1) | IL245619B (zh) |
| IN (1) | IN2013CH05537A (zh) |
| LT (1) | LT3077375T (zh) |
| ME (1) | ME02843B (zh) |
| MX (1) | MX364930B (zh) |
| NZ (1) | NZ719671A (zh) |
| PL (1) | PL3077375T3 (zh) |
| PT (1) | PT3077375T (zh) |
| RS (1) | RS56323B1 (zh) |
| SI (1) | SI3077375T1 (zh) |
| WO (1) | WO2015083179A1 (zh) |
| ZA (1) | ZA201602954B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE050819T2 (hu) * | 2016-05-18 | 2021-01-28 | Suven Life Sciences Ltd | Tiszta 5-HT6 receptor antagonisták kombinációja acetilkolinészteráz inhibitorokkal |
| SG11201809725TA (en) | 2016-05-18 | 2018-12-28 | Suven Life Sciences Ltd | Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist |
| JP6629464B2 (ja) | 2016-05-18 | 2020-01-15 | スヴェン・ライフ・サイエンシズ・リミテッド | 純粋な５−ｈｔ６受容体アンタゴニスト、アセチルコリンエステラーゼ阻害剤及びｎｍｄａ受容体アンタゴニストの３種類の組合せ |
| US20210346374A1 (en) * | 2016-10-03 | 2021-11-11 | Suven Life Sciences Limited | Pharmaceutical compositions of 5-ht6 receptor antagonist |
| MX2019003815A (es) | 2016-10-03 | 2019-08-12 | Suven Life Sciences Ltd | Composiciones farmaceuticas de antagonista del 5-ht6. |
| KR102508303B1 (ko) * | 2017-07-03 | 2023-03-09 | 수벤 라이프 사이언시스 리미티드 | 순수한 5-ht6 수용체 길항제의 신규 용도 |
| MX2022006535A (es) | 2019-12-02 | 2022-09-09 | Suven Life Sciences Ltd | Métodos para tratar síntomas de comportamiento y psicológicos en pacientes con demencia. |
| CN114761008B (zh) | 2019-12-02 | 2024-07-19 | 苏文生命科学有限公司 | 用于在患有痴呆的患者中治疗行为和心理症状的方法 |
| CN111233737B (zh) * | 2020-03-16 | 2021-05-11 | 东莞市东阳光新药研发有限公司 | 芳杂环类衍生物的盐及其用途 |
| CN111362859B (zh) * | 2020-03-16 | 2021-05-11 | 东莞市东阳光新药研发有限公司 | 芳杂环类衍生物的盐及其用途 |
| CN111362858B (zh) * | 2020-03-16 | 2021-05-11 | 东莞市东阳光新药研发有限公司 | 芳杂环类衍生物的盐及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2749846B1 (fr) * | 1996-06-17 | 1998-09-11 | Pf Medicament | Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique |
| SI1581492T1 (sl) | 2002-11-28 | 2008-12-31 | Suven Life Sciences Ltd | N-arilsulfonil-3-substituirani indoli, ki imajo afiniteto za serotoninski receptor, postopek za njihovo pripravo in farmacevtski sestavek, ki jih vsebuje |
| DK1581538T3 (da) * | 2002-12-18 | 2007-06-25 | Suven Life Sciences Ltd | Tetracykliske 3-substituerede indoler med serotoninreceptoraffinitet |
| AU2007257882B2 (en) * | 2006-06-12 | 2011-09-08 | Secura Bio Inc. | Process for making salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide |
-
2014
- 2014-02-20 BR BR112016010788-8A patent/BR112016010788B1/pt active IP Right Grant
- 2014-02-20 EA EA201691161A patent/EA028038B1/ru unknown
- 2014-02-20 EP EP14725245.6A patent/EP3077375B1/en active Active
- 2014-02-20 ES ES14725245.6T patent/ES2638856T3/es active Active
- 2014-02-20 ME MEP-2017-193A patent/ME02843B/me unknown
- 2014-02-20 SI SI201430348T patent/SI3077375T1/sl unknown
- 2014-02-20 PL PL14725245T patent/PL3077375T3/pl unknown
- 2014-02-20 CN CN201480065601.9A patent/CN105814020B/zh active Active
- 2014-02-20 CA CA2929309A patent/CA2929309C/en active Active
- 2014-02-20 IN IN5537CH2013 patent/IN2013CH05537A/en unknown
- 2014-02-20 KR KR1020167013965A patent/KR101808792B1/ko active IP Right Grant
- 2014-02-20 HU HUE14725245A patent/HUE036008T2/hu unknown
- 2014-02-20 DK DK14725245.6T patent/DK3077375T3/en active
- 2014-02-20 WO PCT/IN2014/000109 patent/WO2015083179A1/en active Application Filing
- 2014-02-20 LT LTEP14725245.6T patent/LT3077375T/lt unknown
- 2014-02-20 PT PT147252456T patent/PT3077375T/pt unknown
- 2014-02-20 US US15/100,489 patent/US9540321B2/en active Active
- 2014-02-20 AP AP2016009224A patent/AP2016009224A0/en unknown
- 2014-02-20 MX MX2016006629A patent/MX364930B/es active IP Right Grant
- 2014-02-20 AU AU2014358682A patent/AU2014358682B2/en active Active
- 2014-02-20 JP JP2016535680A patent/JP6151453B2/ja active Active
- 2014-02-20 RS RS20170853A patent/RS56323B1/sr unknown
- 2014-02-20 NZ NZ719671A patent/NZ719671A/en unknown
-
2016
- 2016-05-03 ZA ZA2016/02954A patent/ZA201602954B/en unknown
- 2016-05-11 IL IL245619A patent/IL245619B/en active IP Right Grant
- 2016-12-23 HK HK16114655A patent/HK1226396B/zh unknown
-
2017
- 2017-08-16 HR HRP20171245TT patent/HRP20171245T1/hr unknown
- 2017-08-28 CY CY20171100904T patent/CY1119298T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226396B (zh) | 用於大規模生產1-[(2-溴苯基)磺醯基]-5-甲氧基-3-[(4-甲基-1-呱嗪基)甲基]-1h-吲哚二甲磺酸鹽一水合物的方法 | |
| IL242695B (en) | Device for the production of molybdenum-99 | |
| GB201309639D0 (en) | Electrochemical process for production of graphene | |
| PL2978894T3 (pl) | Sposób wytwarzania papieru lub kartonu | |
| EP3663287C0 (en) | SYNTHESIS OF UROLITHINES ON A PROCESS SCALE | |
| FI20125422A (fi) | Menetelmä biopolttoaineen tai biopolttoainekomponenttien valmistamiseksi | |
| PL3044202T3 (pl) | Mieszaniny enancjomerów i sposób wytwarzania takich mieszanin | |
| GB201421333D0 (en) | Mixed template synthesis of high silica cu-cha | |
| PL3074360T3 (pl) | Sposób wytwarzania cementu portlandzkiego | |
| EP3060523C0 (en) | METHOD FOR PREPARING A HYDROXIDE SLURRY | |
| PT3055280T (pt) | Processo de remoção de enxofre de metanol em bruto | |
| FR3014349B1 (fr) | Procede de decoupe de secteurs pour moules de pneumatiques | |
| PL3087058T3 (pl) | Sposób regioselektywnej syntezy pirazoli | |
| HK1218112A1 (zh) | 多元醇的製造方法 | |
| GB201223271D0 (en) | Process for production of an alkylmethacrylate | |
| SG10201400382TA (en) | Process for producing methacrylic acid | |
| PT2799426T (pt) | Novo processo para a síntese de aminaftona | |
| FR3008093B1 (fr) | Procede de fluoration de composes halogenures de sulfonyle | |
| ZA201603839B (en) | Process for the production of synthesis gas | |
| TH1601003167A (th) | กระบวนการสำหรับการผลิตขนาดใหญ่ของ 1-[(2-โบรโมเฟนิล)ซัลโฟนิล]-5-เมทอกซี-3-[(4-เมทิล-1-พิเพอราซินิล)เมทิล]-1h-อินโดลไดเมซิเลตโมโนไฮเดรต | |
| HRP20190446T1 (hr) | Aktivni metabolit 1-[(2-bromofenil) sulfonil]-5-metoksi-3-[(4-metil-1-piperazinil)metil]-1h-indol dimezilat monohidrata i dimezilat dihidrat sol aktivnog metabolita | |
| DK2964659T3 (da) | Fremgangsmåde til fremstilling af deferasirox | |
| EP2817294A4 (en) | PROCESS FOR THE PREPARATION OF DFMB DERIVATIVES | |
| TH1501001927A (th) | กระบวนการสำหรับการผลิตสารประกอบไอโซไธอะโซล | |
| TH1401004632B (th) | กระบวนการสำหรับการแยกของผสมก๊าซ |